Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday



  • Akero Therapeutics, Inc. AKRO shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
  • Aditxt, Inc. ADTX jumped 113.8% to close at $0.37.
  • Comera Life Sciences Holdings, Inc. CMRA surged 101% to close at $3.86 after a late Monday Form 4 filing showed multiple insider purchases of the stock.
  • NeuroBo Pharmaceuticals, Inc. NRBO climbed 79.3% to close at $29.90 on Tuesday as the stock started trading on a 1-for-30 reverse split basis.
  • 89bio, Inc. ETNB shares rose 40% to close at $7.00. Analysts reportedly said Akero's NASH data could be a positive for the company's Pegoza program in NASH.
  • Motorsport Games Inc. MSGM climbed 28.1% to close at $0.97. Motorsport Games, last month, reported worse-than-expected Q2 EPS results.
  • Akouos, Inc. AKUS gained 28% to close at $4.48. The FDA has signed off Akouos Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene therapy for otoferlin gene (OTOF)-mediated hearing loss.
  • Infobird Co., Ltd IFBD jumped 28% to settle at $2.47.
  • Golden Path Acquisition Corporation GPCO rose 22.4% to settle at $8.69.
  • Ensysce Biosciences, Inc. ENSC gained 22.3% to close at $0.4131.
  • Immuneering Corporation IMRX jumped 22.1% to close at $12.00. Immuneering recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its product candidate IMM-1-104 in development for the treatment of advanced RAS mutant solid tumors.
  • Kiora Pharmaceuticals, Inc. KPRX rose 21% to close at $0.2299.
  • VNET Group, Inc. VNET gained 20.7% to close at $5.66 after the company announced the receipt of a preliminary non-binding proposal to acquire all of its shares and formation of a special committee to review the proposal.
  • Cosmos Holdings Inc. COSM climbed 19.7% to settle at $0.4216. Cosmos Health’s subsidiary SkyPharm recently launched its first Sky Premium Life products on Amazon in the U.S.
  • Palisade Bio, Inc. PALI jumped 18.3% to settle at $0.1782. Palisade Bio was Granted U.S. patent titled 'Administration of serine protease inhibitors to the stomach.'
  • Aprea Therapeutics, Inc. APRE gained 17.7% to close at $0.9299.
  • Phunware, Inc. PHUN surged 15.6% to settle at $1.63.
  • NLS Pharmaceutics AG NLSP gained 14.2% to close at $1.12. Laidlaw & Co. recently initiated coverage on NLS Pharmaceutics with a Buy rating and announced a price target of $6.
  • iBio, Inc. IBIO rose 13.7% to close at $0.3080 after declining over 4% on Monday.
  • Planet Labs PBC PL gained 13.5% to close at $6.15 after the company reported better-than-expected Q2 results and raised guidance.
  • Aehr Test Systems AEHR gained 13.5% to close at $15.99 after the company received a wafer level burn-in system order.
  • HilleVax, Inc. HLVX rose 12.4% to close at $22.01.
  • Hycroft Mining Holding Corporation HYMC rose 12.1% to close at $0.8914. The company earlier reported initial drill results from its 2022-2023 exploration program.
  • Entrada Therapeutics, Inc. TRDA surged 10.3% to settle at $13.14.
  • Tyme Technologies, Inc. TYME gained 9.1% to close at $0.2807 after gaining around 4% on Monday.
  • V2X, Inc. VVX gained 8.6% to close at $41.25.
  • LSB Industries, Inc. LXU gained 6.3% to close at $17.04. Piper Sandler initiated coverage on LSB Industries with an Overweight rating and announced a price target of $26.
  • Syros Pharmaceuticals, Inc. SYRS shares rose 4.9% to close at $0.7659 after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer.
  • Core & Main, Inc. CNM rose 2.5% to close at $25.11 following upbeat Q2 results.


  • Cardiff Oncology, Inc. CRDF shares dipped 41.1% to close at $1.89 on Tuesday. Following a strategic review, Cardiff Oncology decided it will not independently fund any future clinical activities in metastatic castrate-resistant prostate cancer (mCRPC), citing clinical data and therapeutic landscape.
  • Rent the Runway, Inc. RENT shares dropped 38.7% to close at $3.02 after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. Credit Suisse downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4.
  • InMed Pharmaceuticals Inc. INM fell 35.7% to close at $12.07. InMed Pharmaceuticals recently announced a $6 million private placement priced at $8.68 per share.
  • Codiak BioSciences, Inc. CDAK dipped 33.5% to close at $1.11 after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant.
  • Benitec Biopharma Inc. BNTC declined 28.3% to close at $0.4550 as the company reported pricing of $18 million underwritten public offering.
  • Edgewise Therapeutics, Inc. EWTX dropped 24% to settle at $10.32. Edgewise Therapeutics announced a proposed $100 million offering of common stock.
  • Nocera, Inc. NCRA fell 22.5% to close at $1.96.
  • Venus Concept Inc. VERO dropped 21.5% to close at $0.5508.
  • AMTD Digital Inc. HKD declined 21.1% to close at $46.00.
  • Braze, Inc. BRZE fell 19.3% to close at $35.18 after the company reported Q2 earnings results and issued Q3 2023 adjusted EPS guidance below estimates.
  • PolyPid Ltd. PYPD fell 18.7% to settle at $1.39 after jumping 58% on Monday. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
  • Ventoux CCM Acquisition Corp. VTAQ dropped 17.8% to close at $7.11.
  • Relay Therapeutics, Inc. RLAY shares fell 16.6% to close at $24.03. Relay Therapeutics priced 11.32 million share public offering of common stock at $26.50 per share.
  • Soluna Holdings, Inc. SLNH fell 15.6% to close at $2.66.
  • Hut 8 Mining Corp. HUT dipped 15.4% to settle at $2.03.
  • Zentalis Pharmaceuticals, Inc. ZNTL dropped 15.2% to close at $26.45.
  • Jasper Therapeutics, Inc. JSPR fell 15.1% to settle at $1.58.
  • Boxed, Inc. BOXD declined 14.8% to settle at $0.9283.
  • Kingsoft Cloud Holdings Limited KC fell 14.4% to close at $2.26.
  • Innovid Corp. CTV fell 14.2% to close at $3.08. Morgan Stanley initiated coverage on Innovid with an Underweight rating and announced a price target of $2.7.
  • The RealReal, Inc. REAL declined 14.1% to close at $2.26.
  • Magic Empire Global Limited MEGL dropped 14% to close at $5.16.
  • Syneos Health, Inc. SYNH fell 13.7% to settle at $54.72.
  • LumiraDx Limited LMDX declined 13.6% to settle at $1.33.
  • Rubius Therapeutics, Inc. RUBY fell 13.4% to close at $0.9270 after the company discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
  • The Children's Place, Inc. PLCE declined 13.4% to settle at $35.17.
  • Rocket Pharmaceuticals, Inc. RCKT slipped 13.4% to close at $13.91.
  • Unity Software Inc. U dropped 13.4% to close at $36.66 after Applovin announced it does not intend to submit another proposal to combine with the company and has withdrawn its Aug. 9 proposal.
  • Carvana Co. CVNA fell 12.9% to close at $36.81.
  • MicroStrategy Incorporated MSTR dropped 12.1% to close at $231.25 after August CPI data showed greater-than-expected US inflation.
  • WalkMe Ltd. WKME declined 11.9% to close at $9.74. WalkMe announced the departure of Chief Financial Officer Andrew Casey.
  • Pacific Biosciences of California, Inc. PACB dipped 11.7% to close at $6.14.
  • Asana, Inc. ASAN fell 11.5% to close at $25.42.
  • Wayfair Inc. W fell 11.1% to close at $49.76.
  • Upstart Holdings, Inc. UPST fell 10.9% to close at $24.97.
  • Peloton Interactive, Inc. PTON fell 10.3% to close at $9.91 after the company announced Executive Chair John Foley will step down, effective Sept. 12. Karen Boone has been elected Chairperson of the Board.
  • BridgeBio Pharma, Inc. BBIO fell 10.1% to close at $11.11.
  • Crocs, Inc. CROX dropped 9.8% to settle at $75.39 amid overall market weakness as August CPI readings showed inflation came in greater than expected.
  • NVIDIA Corporation NVDA tumbled 9.5% to close at $131.31. Shares of semiconductor stocks at large traded lower after August CPI data showed greater-than-expected US inflation, which has caused economic concerns and raised expectations for aggressive Fed policy. Fed rate hikes could drive a slowdown in the economy, which could pressure demand in semiconductor and chip end markets.
  • Tuesday Morning Corporation TUEM fell 8.8% to close at $0.1766. The company recently announced it has entered into an agreement to secure $32 million in convertible debt financing.
  • Coinbase Global, Inc. COIN declined 8.8% to settle at $75.25 as cryptocurrencies fell following worse-than-expected US inflation data.
  • Amazon.com, Inc. AMZN dipped 7.1% to close at $126.82 after August CPI data showed greater-than-expected US inflation.
  • AppLovin Corporation APP fell 6.4% to close at $26.68. Applovin announced it does not intend to submit another proposal to combine with Unity Software and has withdrawn its Aug. 9 proposal.
  • Apple Inc. AAPL fell 5.9% to close at $153.84 amid overall market weakness after August CPI readings showed inflation came in greater than expected.
  • Microsoft Corporation MSFT fell 5.5% to settle at $251.99 after August CPI data showed greater-than-expected US inflation.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasDiversified ChemicalsMaterialsMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!